510(k) · Cleared
ClearedVoxar 3D Enterprise, Model 6.1
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Barcoview Mis Edinburgh · LLZ System, Image Processing, Radiological
Cleared on Mar 29, 2006 after a 30-day review. FDA’s file for it is a 510(k) statement, which names no predicate. 59 later devices descend from it.
- Decided
- Mar 29, 2006
- Review
- 30 days
- Class
- Class II
- Product code
- LLZ
- Recalls
- None
- Predicates
- 0
59 later devices descend from it, 4 citing it directly.
- This deviceK060505 Voxar 3D Enterprise, Model 6.1Barcoview Mis Edinburgh · 2006
- Descendant · cites it directly · 51 of its ownK072653 3VISEON/Surgery3Mensio Medical Imaging BV · 2008
- Descendant · 2 generations on · 49 of its ownK120367 3MENSIO WorkstationPie Medical Imaging BV · 2012
- Descendant · 3 generations on · 19 of its ownK153736 3mensio WorkstationPie Medical Imaging BV · 2016 · Recalled
- Descendant · 3 generations on · 16 of its ownK141475 EndosizeTherenva Sas · 2014
- Descendant · 4 generations on · 13 of its ownK160376 EndoSizeTherenva Sas · 2016
Showing 5 of 59 descendants. See all descendants
Descendants cleared per year
Most influential descendants
Showing 5 of 59 · See all- K0726533VISEON/Surgery3Mensio Medical Imaging BV · 2008 · cites it directly51descendants
- K1203673MENSIO WorkstationPie Medical Imaging BV · 2012 · 2 generations on49descendants
- K1537363mensio WorkstationPie Medical Imaging BV · 2016 · 3 generations on19descendants
- K141475EndosizeTherenva Sas · 2014 · 3 generations on16descendants
- K160376EndoSizeTherenva Sas · 2016 · 4 generations on13descendants
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| 0 (this device) | K060505 | Voxar 3D Enterprise, Model 6.1 | Barcoview Mis Edinburgh | 2006 | — |
| +1 | K072653 | 3VISEON/Surgery | 3Mensio Medical Imaging BV | 2008 | — |
| +2 | K120367 | 3MENSIO Workstation | Pie Medical Imaging BV | 2012 | — |
| +3 | K153736 | 3mensio Workstation | Pie Medical Imaging BV | 2016 | 1 |
| +3 | K141475 | Endosize | Therenva Sas | 2014 | — |
| +4 | K160376 | EndoSize | Therenva Sas | 2016 | — |
Descendants by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 2008 | 2 | 0 |
| 2009 | 1 | 0 |
| 2010 | 1 | 0 |
| 2012 | 1 | 0 |
| 2013 | 2 | 0 |
| 2014 | 2 | 0 |
| 2015 | 2 | 0 |
| 2016 | 2 | 0 |
| 2017 | 1 | 0 |
| 2018 | 2 | 0 |
| 2019 | 3 | 0 |
| 2020 | 3 | 0 |
| 2021 | 3 | 0 |
| 2022 | 6 | 0 |
| 2023 | 4 | 0 |
| 2024 | 5 | 0 |
| 2025 | 10 | 0 |
| 2026 | 9 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA 510(k) statement (indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in LLZ? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
Top candidate predicates for a new LLZ device
- #1 K230955 syngo Application Softwarescore 21.5 · 11 generations · no Class I recall
- #2 Held for the reportin the report
- #3 Held for the reportin the report
What was it cleared against?
FDA’s file for it is a 510(k) statement, which names no predicate.
What descends from it? (59)
See all 594 later devices cite it directly; ranked here by how many devices descend from each in turn.
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
What does this lineage say?
- Of its descendants, K072653 (3Mensio Medical Imaging BV, 2008) has gone furthest, with 51 descendants of its own.
How does its category compare?
All LLZ devicesLLZ System, Image Processing, Radiological: FDA decisions, review times, recalls and adverse event reports over 20 years.
FDA decisions per year · LLZ
58in 2025
2026 to Oct 25, outlined.
Median 510(k) review, days · LLZ
173in 2025
Receipt to decision; years with fewer than 3 clearances left blank.
Recalls per year · LLZ
11in 2025
Class I (0 since 2007) Class II/III not classified
Adverse event reports per year · LLZ
116in 2025
MAUDE reports naming product code LLZ, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 76 | 36 | 20 | 152 |
| 2008 | 94 | 52 | 32 | 154 |
| 2009 | 70 | 62 | 21 | 145 |
| 2010 | 51 | 98 | 17 | 145 |
| 2011 | 106 | 79 | 30 | 454 |
| 2012 | 82 | 87 | 12 | 266 |
| 2013 | 95 | 84 | 64 | 1,130 |
| 2014 | 78 | 89 | 6 | 15,631 |
| 2015 | 64 | 90 | 16 | 211 |
| 2016 | 82 | 90 | 12 | 290 |
| 2017 | 78 | 107 | 5 | 104 |
| 2018 | 104 | 105 | 7 | 72 |
| 2019 | 74 | 107 | 2 | 88 |
| 2020 | 81 | 115 | 6 | 82 |
| 2021 | 83 | 116 | 3 | 70 |
| 2022 | 65 | 137 | 4 | 28 |
| 2023 | 87 | 157 | 8 | 26 |
| 2024 | 62 | 131 | 6 | 42 |
| 2025 | 58 | 173 | 11 | 116 |
| 2026 | 45 | 110 | 14 | — |
What is it indicated for?
The Voxar 3D product family is a suite of products that is intended to provide Physicians, Clinicians and Radiologists with tools to aid them in reading and interpreting DICOM compliant tomographic medical imaging. The Voxar 3D product family provides several levels of functionality to the user * Basic analysis tools they use on a daily basis, such as 2D review, orthogonal Multi Planar Reconstructions (MPRs), oblique MPRs, curved/cross-curved MPRs, slab…
Read the full statement (197 words)
The Voxar 3D product family is a suite of products that is intended to provide Physicians, Clinicians and Radiologists with tools to aid them in reading and interpreting DICOM compliant tomographic medical imaging.
The Voxar 3D product family provides several levels of functionality to the user
* Basic analysis tools they use on a daily basis, such as 2D review, orthogonal Multi Planar Reconstructions (MPRs), oblique MPRs, curved/cross-curved MPRs, slab MPRs, AveIP, MIP, MinIP, measurements, annotations, reporting, distribution, etc
* Tools for in-depth analysis, such as segmentation, endoscopic review, colour VR slab, 3D volume review, path definition and boundary detection, PET imagery analysis, etc
* Specialist tools and workdflow enhancements for specific clinical applications which provide targeted workflows, custom Ul, targeted measurement and reporting functions including Colon Screening (which is intended for the screening of patients for colonic polyps, turnours and other lesions using tomographic Colonography), Calcium Scoring (which is intended for non-invasive identification and quantification of calcified atherosclerotic plaques in the coronary arteries using tomographic medical image data and clinically accepted calcium scoring algorithms), Vessel Analysis (which is intended for the qualitative and quantitative analysis of tomographic angiographic studies to evaluate occlusive and aneurysmal disease), etc-
Indications for use as stated in the FDA 510(k) statement.
https://510kreport.com/device/K060505 · printed Nov 5, 2026
Cite this page
510(k) Report. “K060505: Voxar 3D Enterprise, Model 6.1.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K060505
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026